Abstract
People with MS often face complex treatment decisions, and it may be worth involving trusted patient organisations to support and enhance the process of shared decision-making. Claire Winchester elaborates.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
